CELV (Cellev8 Nutrition) Current Deferred Revenue: $0.02 Mil (As of Nov. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CELV Cellev8 Nutrition Inc CELV
30 GF Score
Price $0.07
View Full Analysis

What is Cellev8 Nutrition Current Deferred Revenue?

Cellev8 Nutrition CELV +1.15% 30 Current Deferred Revenue is $0.02 Mil as of Nov. 2015. GuruFocus rates CELV with a GF Score™ of 30/100.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Cellev8 Nutrition's current deferred revenue for the quarter that ended in Nov. 2015 was $0.02 Mil.

Cellev8 Nutrition Current Deferred Revenue Related Terms

Cellev8 Nutrition Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Cellev8 Nutrition's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellev8 Nutrition Current Deferred Revenue Chart

Cellev8 Nutrition Annual Data
Trend Nov07 Nov08 Nov09 Nov10 Nov14 Nov15
Current Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.02

Cellev8 Nutrition Semi-Annual Data
Nov07 Nov08 Nov09 Nov10 Nov14 Nov15
Current Deferred Revenue Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.02
CELV
30GF Score
Cellev8 Nutrition Inc CELV
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.02 Mil mean?
Cellev8 Nutrition (CELV) has a Current Deferred Revenue of $0.02 Mil as of Nov. 2015. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Cellev8 Nutrition and its competitors.
Is Cellev8 Nutrition's Current Deferred Revenue too high?
Cellev8 Nutrition's current Current Deferred Revenue is $0.02 Mil. Overall, Cellev8 Nutrition has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Cellev8 Nutrition's Current Deferred Revenue compare to LFVN and MAMA?
Cellev8 Nutrition's Current Deferred Revenue of $0.02 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Consumer Packaged Goods company?
A good Current Deferred Revenue depends on the Consumer Packaged Goods industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Cellev8 Nutrition and its competitors. Cellev8 Nutrition's current Current Deferred Revenue is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellev8 Nutrition stock overvalued right now?
Cellev8 Nutrition (CELV) has a current Current Deferred Revenue of $0.02 Mil. The current Current Deferred Revenue is $0.02 Mil. Cellev8 Nutrition's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Cellev8 Nutrition (CELV), the current Current Deferred Revenue is $0.02 Mil as of Nov. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellev8 Nutrition Business Description

Address 3361 Fairline Farms Road, Unit No. 3, Wellington, FL, USA, 33414
Cellev8 Nutrition Inc is engaged in the development, markets, and sells a line of proprietary blended cellular therapeutics named Cellev8. Its products are based on formulations containing Superoxide Dismutase (SOD) and are developed for health-related applications.
30GF Score

Get the complete analysis for CELV

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price